Jeffrey C. Pepe

Insider Reports History

Entity
Individual
Location
C/O Silverback Therapeutics, Inc., 500 Fairview Avenue N, Suite 600, Seattle, WA
Signature
/s/ Jeffrey C. Pepe
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey C. Pepe:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Silverback Therapeutics, Inc. Interim CEO and GC Common Stock 52.3K $198K $3.78 Sep 2, 2022 Direct

Insider Reports Filed by Jeffrey C. Pepe

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SPRY Silverback Therapeutics, Inc. Sep 2, 2022 0 $0 3 Sep 8, 2022 Interim CEO and GC